InMed Pharmaceuticals appoints Neil Klompas to board of directors

InMed Pharmaceuticals Inc. (NASDAQ: INM) appointed Neil Klompas as a director to its board, effective October 9, 2025. The pharmaceutical company also expanded its board size to five members.

The board made the appointment on October 7, 2025, according to a company statement. Klompas may be assigned to board committees, though specific committee appointments have not been determined.

Klompas's term as a board member will expire immediately before the company's Annual General Meeting scheduled for 2025. The company did not provide details about Klompas's background or experience in the announcement.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49